Study finds sharp rise in diabetes

LONDON – The number of adults worldwide with diabetes has more than doubled in three decades, jumping to an estimated 347 million, a new study says.

Much of that increase is due to aging populations – since diabetes typically hits in middle age – and population growth, but part of it has also been fueled by rising obesity rates.

With numbers climbing almost everywhere, experts said the disease is no longer limited to rich countries and is now a global problem. Countries in which the numbers rose fastest include Cape Verde, Samoa, Saudi Arabia, Papua New Guinea, and the U.S.

“Diabetes may well become the defining issue of global health for the next decade,” said Majid Ezzati, chairman of global environmental health at Imperial College London, one of the study authors.

He noted the figures don’t reflect the generations of overweight children and young adults who have yet to reach middle age. That could create a massive burden on health systems.

“We are not at the peak of this wave yet,” he said. “And unlike high blood pressure and cholesterol, we still don’t have great treatments for diabetes.”

Still, in Britain and elsewhere in Western Europe, despite growing waistlines, there was only a slight rise in diabetes. Experts weren’t sure why and said there could be several reasons, including worse detection of the disease, genetic differences, or perhaps the Europeans were better at getting heavy people to reduce their chances of developing diabetes.

Women in Singapore, France, Italy and Switzerland remained relatively slim and had virtually no change in their diabetes rates. Numbers also stayed flat in sub-Saharan Africa, central Latin America and rich Asian countries.

Type 2 is the most common type of diabetes and is often tied to obesity. It develops when the body doesn’t produce enough insulin to break down glucose, inflating blood sugar levels. The disease can be managed with diet, exercise and medication but chronically high blood sugar levels causes nerve damage, which can result in kidney disease, blindness and amputation.

For their estimate, Ezzati and colleagues examined more than 150 national health surveys and studies in 199 countries and territories. They used modeling to estimate cases for another 92 countries.

The new study was paid for by the Bill & Melinda Gates Foundation and the World Health Organization. It was published Saturday in the journal Lancet.